Yong Du

Dr. Yong Du


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Clinical Radiology
Verified
Journal Article
Closed access
XXX.-X. Xu
X.-X. Xu
BLB. Li
B. Li
HYH.-F. Yang
H.-F. Yang
YDYong Du
Yong Du
YLY. Li
Y. Li
QGQiyong Gong
Qiyong Gong

1 January 2014 in Clinical Radiology
Verified
Journal Article
Closed access
YLY. Li
Y. Li
YDYong Du
Yong Du
TLT.Y. Luo
T.Y. Luo
HYH.F. Yang
H.F. Yang
JYJ.H. Yu
J.H. Yu
BLB. Li
B. Li

1 November 2015 in Clinical Radiology
Verified
Journal Article
Closed access
YLY. Li
Y. Li
YDYong Du
Yong Du
TLT.Y. Luo
T.Y. Luo
HYH.F. Yang
H.F. Yang
JYJ.H. Yu
J.H. Yu
BLB. Li
B. Li

11 December 2020 in Oncology Letters
Verified
Journal Article
Open access
PDF file
XFXu Feng
Xu Feng
PHPan He
Pan He
CZChen Zeng
Chen Zeng
YLYe-Han Li
Ye-Han Li
SDSushant K. Das
Sushant K. Das
YDYong Du
Yong Du
Several solid tumors (for example leiomyosarcoma, melanoma and hepatocellular carcinoma) possess areas of hypoxia, which underlies one of the primary reasons of failure of conventional anticancer therapies. The areas of poor vascularization are insensitive to radiotherapy and chemotherapeutic drugs. Conversely, the hypoxic regions of tumors provide an ideal environment for anaerobic bacteria. The attenuated anaerobic bacterium, Clostridium novyi‑NT (C. novyi‑NT), is highly sensitive to oxygen and can target the destruction of hypoxic and necrotic areas of tumors, inducing oncolysis and characteristics indicative of an immune response. Theoretically, chemotherapy, radiotherapy and immunotherapy combined with bacterial therapy can be used as a novel means of treating solid tumors, promoting tumor regression and inhibiting metastasis formation with a notable beneficial effect. The present review discusses the molecular mechanisms of combined bacteriolytic therapy, predominantly focusing on C. novyi‑NT, and summarizes the findings of previous studies on experimental animal models, including its efficacy and safety via different drug delivery routes. This strategy has great potential to overcome the limitations of conventional cancer therapy, resulting in improved treatments, and thus potentially improved outcomes for patients.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
XWXiaoqin Wei
Xiaoqin Wei
XCXiaowen Chen
Xiaowen Chen
CLCe Lai
Ce Lai
YZYuanzhong Zhu
Yuanzhong Zhu
HYHan Feng Yang
Han Feng Yang
YDYong Du
Yong Du
Liver image segmentation has been increasingly employed for key medical purposes, including liver functional assessment, disease diagnosis, and treatment. In this work, we introduce a liver image segmentation method based on generative adversarial networks (GANs) and mask region‐based convolutional neural networks (Mask R‐CNN). Firstly, since most resulting images have noisy features, we further explored the combination of Mask R‐CNN and GANs in order to enhance the pixel‐wise classification. Secondly, k‐means clustering was used to lock the image aspect ratio, in order to get more essential anchors which can help boost the segmentation performance. Finally, we proposed a GAN Mask R‐CNN algorithm which achieved superior performance in comparison with the conventional Mask R‐CNN, Mask‐CNN, and k‐means algorithms in terms of the Dice similarity coefficient (DSC) and the MICCAI metrics. The proposed algorithm also achieved superior performance in comparison with ten state‐of‐the‐art algorithms in terms of six Boolean indicators. We hope that our work can be effectively used to optimize the segmentation and classification of liver anomalies.

1 March 2013 in Clinical Imaging
Verified
Journal Article
Closed access
BLBing Li
Bing Li
XXXiao Xue Xu
Xiao Xue Xu
YDYong Du
Yong Du
HYHan Feng Yang
Han Feng Yang
YLYang Li
Yang Li
WWWen Xuan Wang
Wen Xuan Wang